lenalidomide,idecabtagene vicleucel
bms,2seventy bio
['bet', 'mmsm', 'ide-cel', 'karmma', 'karmma-2']
karmma-2 ide-cel in high risk mm after asct. #mmsm #ash22 
Cellular Therapy  @MGHCancerCenter @Harvardmed. Tweets and opinions are my own. #CART #Multiple_Myeloma